Randomised arm | Drug | Number | Dose 1 | Dose 2 (24 h later) (± 1 h) | Interval between the last PrEP dose and surgery (h) (± 1 h) | Analysis group (Fig. 1) |
---|---|---|---|---|---|---|
1 | Control | 16 | – | – | – | X |
2 | FTC-TDF | 16 | 2 tablets | – | 5 | A |
3 | FTC-TDF | 16 | 2 tablets | – | 21 | A |
4 | FTC-TDF | 16 | 2 tablets | 1 tablet | 5 | B |
5 | FTC-TDF | 16 | 2 tablets | 1 tablet | 21 | B |
6 | FTC-TAF | 16 | 2 tablets | – | 5 | C |
7 | FTC-TAF | 16 | 2 tablets | – | 21 | C |
8 | FTC-TAF | 16 | 2 tablets | 1 tablet | 5 | D |
9 | FTC-TAF | 16 | 2 tablets | 1 tablet | 21 | D |